We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Do not stop your hypertriglyceridemia treatment without a discussion with your doctor
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
Competent authorities of exporting countries should use the relevant model health certificate as a template to create a version exporters can apply for to export fish oil to Great Britain, the Channel Islands or Isle of Man.
Residential Property Tribunal Decision of Judge Professor R Percival and Mr A Fonka on 6 May 2021
Details of the consent for Rothamsted Research to release genetically modified camelina, reference 16/R8/01.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
The Scientific Advisory Committee on Nutrition and Committee on Toxicity advice on benefits and risks related to fish consumption
Residential Property Tribunal Decision of Judge F J Silverman MA LLM and Mr S Wheeler MCIEH CEnvH on 19 June 2023
The advice of the Advisory Committee on Releases to the Environment on the release of genetically modified camelina.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Deficiencies in Omega’s pharmacovigilance system are not thought to affect the safety of the products that they market.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.